The "Fast Money" traders share their first moves for the market open. » Read More
CNBC's Dominic Chu reports on the record amounts of cash being hoarded by some of America's biggest companies. The "Fast Money" traders weigh in.
Joe Dennison, Zevenbergen Capital Investments Associate Portfolio Manager, discusses the SolarCity bond offering to Elon Musk and his cousins the Rive brothers. The "Fast Money" traders weigh in.
The "Fast Money" traders discuss the plunge in the GDX gold miners ETF with gold hitting a one-month low ahead of Fed Chair Janet Yellen's remarks at Jackson Hole.
Umer Raffat, Evercore ISI Senior Analyst, discusses how Mylan's stock price may be affected long-term by the EpiPen pricing saga.
The "Fast Money" traders discuss the effect of Mylan's EpiPen pricing controversy on the biotech sector.
"Fast Money" trader Dan Nathan looks at a bullish bet on retail giant Wal-Mart.
The "Fast Money" traders share their final trades of the day.
The "Fast Money" traders share their first moves for the market open.
On Tuesday, the SPDR S&P Homebuilders ETF gained about 1.8 percent after Toll Brothers reported better-than-expected results.
Paul Hickey, Bespoke Investment Group Co-Founder, discusses why there might be trouble ahead for big tech names Acacia Communications and Twilio after their IPOs this year.
Chris Verrone, Strategas Research Partners Head of Technical Analysis & Partner, goes to the charts to look at the tight trading range in the markets and whether investors should be worried.
The "Fast Money" traders debate the trade on Tesla following the news of new Model S and Model X vehicles and a more powerful battery.
CNBC's Bob Pisani reports on the returns of IPOs so far this year, with the technology sector leading the pack.
The "Fast Money' traders discuss the big move closer to $50 oil during the day.
CNBC contributor Mike Khouw discusses a big bet on Best Buy following its earnings release.
CNBC's Meg Tirrell reports on other price hikes from Mylan apart from its controversial raise of its EpiPen. The "Fast Money" traders weigh in on the drug pricing debate.
Melissa Lee is the host of CNBC's “Fast Money” and “Options Action.”
Chief Market Strategist & Director of Advisor Advocacy, Private Advisor Group
CEO & Co-founder, Metropolitan Capital Advisors
Director of Institutional Sales Stuart Frankel & Co. Inc.
Founder and Managing Member, Brian Kelly Capital LLC
Co-Founder Najarian Family Office and Najarian Advisors
Co-Founder, Najarian Family Office and Najarian Advisors
Co-Founder and Editor, RiskReversal.com
Managing Partner, Triogem Asset Management, Founder, EmergingMoney.com
The "Halftime Report" traders give their final trades of the show.
Kevin O'Leary, O'Shares Investments chairman, says there's nothing to lose by waiting in cash.
Richard Turnill, BlackRock global chief investment strategist, thinks emerging markets can become more sustainable and explains why he is underweight Europe.